arrow
Return

Minimal clinically important differences in the Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0) in patients with symptomatic spinal metastases

delete2026-06-10
delete0
delete
OA
AI
A
Anne L. Versteeg *
A
A. Sahgal
I
I. Laufer
L
L.D. Rhines
D
D.M. Sciubba
J
J.M. Schuster
M
M.H. Weber
A
A. Lazary
S
S. Boriani
C
C. Bettegowda
M
M.G. Fehlings
M
M.J. Clarke
P
P.M. Arnold
Z
Z.L. Gokaslan
O
O. Barzilai
N
N. Dea
A
A. Gasbarrini
C
C. Netzer
J
J.J. Reynolds
J
JJ. Verlaan
DOI:10.1016/j.spinee.2026.05.007delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
It is currently unknown what absolute change in Spine Oncology Study Group Outcomes Questionnaire (SOSGOQ2.0) represents a clinically meaningful change for a patient which causes challenges with the interpretation of the SOSGOQ2.0 total score or domain scores.
Keywords:
spinal metastases
surgery
radiotherapy
quality of life
minimal clinically important difference
MCID
patient reported outcomes
minimally clinically important difference
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

T
The Spine Journal
IF:
0
Papers:
248
Citations:
0

Organization

No organization information available